Highlights and Quick Summary
- EPS (Basic) for the quarter ending June 30, 2022 was -2.13 (a 19.66% increase compared to previous quarter)
- Year-over-year quarterly EPS (Basic) increased by 12.7%
- Annual EPS (Basic) for 2021 was -7.43 (a 11.9% increase from previous year)
- Annual EPS (Basic) for 2020 was -6.64 (a 55.5% increase from previous year)
- Annual EPS (Basic) for 2019 was -4.27 (a 55.27% increase from previous year)
- Twelve month EPS (Basic) ending June 30, 2022 was -7.83 (a 6.1% increase compared to previous quarter)
- Twelve month trailing EPS (Basic) increased by 20.83% year-over-year
Trailing EPS (Basic) for the last four month:
| 30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
|---|---|---|---|
| -7.83 | -7.38 | -7.43 | -6.48 |
Visit stockrow.com/PTCT
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Basic) of PTC Therapeutics, Inc.
Most recent EPS (Basic)of PTCT including historical data for past 10 years.Interactive Chart of EPS (Basic) of PTC Therapeutics, Inc.
PTC Therapeutics, Inc. EPS (Basic) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -2.13 | -1.78 | – | – | – |
| 2021 | -2.03 | -1.89 | -1.68 | -1.83 | -7.43 |
| 2020 | -1.08 | -1.03 | -2.78 | -1.81 | -6.64 |
| 2019 | -1.37 | -1.06 | -0.75 | -1.29 | -4.27 |
| 2018 | -0.96 | -1.06 | -0.21 | -0.46 | -2.75 |
| 2017 | 0.03 | -0.82 | -0.44 | -0.85 | -2.02 |
| 2016 | -0.78 | -1.03 | -1.14 | -1.22 | -4.17 |
| 2015 | -1.5 | -1.27 | -1.14 | -1.15 | -5.07 |
| 2014 | -0.84 | -0.93 | -0.86 | -0.58 | -2.97 |
| 2013 | -0.75 | -0.19 | -5.51 | -2.08 | -5.18 |
| 2012 | 168.0 | – | – | – | 9.4 |
Business Profile of PTC Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology